Page last updated: 2024-08-23

amikacin and phosphatidylinositol 5-phosphate

amikacin has been researched along with phosphatidylinositol 5-phosphate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ciciriello, F; Cirillo, DM; D'Andrea, MM; De Santis, F; Fraziano, M; Henrici De Angelis, L; Lorè, NI; Lucidi, V; Olimpieri, T; Poerio, N; Riva, C; Rossi, M	1

Other Studies

1 other study(ies) available for amikacin and phosphatidylinositol 5-phosphate

Article	Year
Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection. Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Liposomes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phagosomes; Phosphatidylinositol Phosphates; Reactive Oxygen Species	2022

Article

Year

Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.

Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

Topics: Amikacin; Animals; Anti-Bacterial Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Liposomes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phagosomes; Phosphatidylinositol Phosphates; Reactive Oxygen Species

2022